Tracking the entry routes of hepatitis C virus as a surrogate of HIV in an HIV-low prevalence country, the Philippines

Journal of Medical Virology

Volumn 81, Issue 7, 2009, Pages 1157-1162

  Kageyama, Seiji ^a,b   Agdamag, Dorothy May D ^a,c   Alesna, Evelyn T ^d   Abellanosa Tac An, Ilya P ^e   Corpuz, Aura C ^f   Telan, Elizabeth Freda O ^c   Que, Ernesto R ^g   Leaño, Prisca Susan A ^c   Jereza, Lourdes D ^h   Emphasis, Yvonne Ethyl E ^d   Prasetyo, Afiono A ^b   Tanimoto, Tomoaki ^a   Ichimura, Hiroshi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

^c San Lazaro Hospital   (Philippines)

^d Cebu Center for Infectious Diseases   (Philippines)

^e Cebu City Health Office   (Philippines)

^f DEPARTMENT OF HEALTH   (Philippines)

^g National Kidney Transplant Institute   (Philippines)

^h University of Southern Philippines   (Philippines)

Author keywords

HCV epidemic; HIV epidemic; Injecting drug users; Philippines

Indexed keywords

VIRUS RNA; E1 PROTEIN, HEPATITIS C VIRUS; GLYCOPROTEIN E2, HEPATITIS C VIRUS; NS 5 PROTEIN, HEPATITIS C VIRUS; NS-5 PROTEIN, HEPATITIS C VIRUS; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN;

ARTICLE; DISEASE MARKER; GENE SEQUENCE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHILIPPINES; PHYLOGENY; PREVALENCE; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; VIRUS DETECTION; VIRUS ENTRY; VIRUS STRAIN; CLASSIFICATION; CLUSTER ANALYSIS; DISEASE TRANSMISSION; DNA SEQUENCE; EPIDEMIOLOGY; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; SUBSTANCE ABUSE; VIROLOGY;

HEPATITIS C VIRUS;

CLUSTER ANALYSIS; EPIDEMIOLOGY, MOLECULAR; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HUMANS; MALE; MOLECULAR SEQUENCE DATA; PHILIPPINES; PHYLOGENY; POLYMORPHISM, GENETIC; PREVALENCE; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY; SUBSTANCE ABUSE, INTRAVENOUS; VIRAL ENVELOPE PROTEINS; VIRAL NONSTRUCTURAL PROTEINS;

EID: 67649989071     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21516     Document Type: Article

References (23)

1. REFERENCES Aceijas C, Stimson GV, HickmanM, Rhodes T. 2004. Global overview of injecting drug use and HIV infection among injecting drug users. AIDS 18:2295-2303.
2. Agdamag DM, Kageyama S, Alesna ET, Solante RM, Leano PS, Heredia AM, Abellanosa-Tac-An IP, Vibal ET, Jereza LD, Ichimura H. 2005. Rapid spread of hepatitis C virus among injecting-drug users in the Philippines: Implications for HIV epidemics. J Med Virol 77:221-226.
3. Alter MJ. 2006. Epidemiology of viral hepatitis and HIV co-infection. J Hepatol 44:S6-S9.
4. Bukh J, Apgar CL, Yanagi M. 1999. Toward a surrogate model for hepatitis C virus: An infectious molecular clone of the GB virus-B hepatitis agent. Virology 262:470-478.
5. Ghys PD, Bazant W, Monteiro MG, Calvani S, Lazzari S. 2001. The epidemics of injecting drug use and HIV in Asia. AIDS 15:S91-S99.
6. Heyndrickx L, Janssens W, Zekeng L, Musonda R, Anagonou S, Van der Auwera G, Coppens S, Vereecken K, De Witte K, Van Rampelbergh R, Kahindo M, Morison L, McCutchan FE, Carr JK, Albert J, Essex M, Goudsmit J, Asjo B, Salminen M, Buve A, van DerGroen G. 2000. Simplified strategy for detection of recombinant human immunodeficiency virus type 1 groupMisolates by gag/env heteroduplex mobility assay. Study Group onHeterogeneity of HIV Epidemics in African Cities. J Virol 74:363-370.
7. Kageyama S, Agdamag DM, Alesna ET, Leano PS, Heredia AM, Abellanosa-Tac-An IP, Jereza LD, Tanimoto T, Yamamura J, Ichimura H. 2006. A natural inter-genotypic (2b/1b) recombinant of hepatitis C virus in the Philippines. J Med Virol 78:1423-1428.
8. Lee HC, Ko NY, Lee NY, Chang CM, Ko WC. 2008. Seroprevalence of viral hepatitis and sexually transmitted disease among adults with recently diagnosed HIV infection in Southern Taiwan, 2000-2005: Upsurge in hepatitis C virus infections among injection drug users. J Formos Med Assoc 107:404-411.
9. MAP. 2005. Drug injection and HIV/AIDS in Asia.
10. MemonMI,Memon MA. 2002.Hepatitis C: An epidemiological review. J Viral Hepat 9:84-100.
11. Miller CL, Wood E, Spittal PM, Li K, Frankish JC, Braitstein P, Montaner JS, Schechter MT. 2004. The future face of coinfection: Prevalence and incidence of HIV and hepatitis C virus coinfection among young injection drug users. J Acquir Immune Defic Syndr 36:743-749.
12. Miura T, Sakuragi J, Kawamura M, Fukasawa M, Moriyama EN, Gojobori T, Ishikawa K, Mingle JA, Nettey VB, Akari H, Enami M, Tsujimoto H, Hayami M. 1990. Establishment of a phylogenetic survey system for AIDS-related lentiviruses and demonstration of a new HIV-2 subgroup. AIDS 4:1257-1261.
13. Patrick DM, Tyndall MW, Cornelisse PG, Li K, Sherlock CH, Rekart ML, Strathdee SA, Currie SL, Schechter MT, O'Shaughnessy MV. 2001. Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection. Can Med Assoc J 165: 889-895.
14. Perriere G, Gouy M. 1996. WWW-query:An on-line retrieval system for biological sequence banks. Biochimie 78:364-369.
15. Poynard T, Yuen MF, Ratziu V, Lai CL. 2003. Viral hepatitis C. Lancet 362:2095-2100.
16. Ruxrungtham K, Brown T, Phanuphak P. 2004. HIV/AIDS in Asia. Lancet 364:69-82.
17. Thompson JD, Higgins DG, Gibson TJ. 1994. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22:4673-4680.
18. UNAIDS/WHO. 2007. AIDS epidemic update: December 2007.
19. UNAIDS/WHO. 2008a. Asia: AIDS epidemic update, Regional Summary.
20. UNAIDS/WHO. 2008b. Epidemiological Fact Sheets on HIV/AIDS, Core data on epidemiology and response. Philippines.
21. White PA, Zhai X, Carter I, Zhao Y, Rawlinson WD. 2000. Simplified hepatitis C virus genotyping by heteroduplex mobility analysis. J Clin Microbiol 38:477-482.
22. Yanase Y, Ohida T, Kaneita Y, Agdamag DM, Leano PS, Gill CJ. 2007. The prevalence of HIV, HBV and HCV among Filipino blood donors and overseas work visa applicants. Bull World Health Organ 85:131-137.
23. Zhang L, Chen Z, Cao Y,YuJ, Li G,YuW, YinN,Mei S, Li L, Balfe P,He T, Ba L, Zhang F, Lin HH, Yuen MF, Lai CL, Ho DD. 2004. Molecular characterization of human immunodeficiency virus type 1 and hepatitisCvirus in paid blood donors and injection drug users in china. J Virol 78:13591-13599.